Literature DB >> 18404238

Reply: "Treatment-of-choice for Buerger's disease (thromboangiitis obliterans): still an unresolved issue".

Hassan Tavakoli, Javad Salimi, Armin Rashidi.   

Abstract

Entities:  

Mesh：

Year:  2008        PMID： 18404238     DOI： 10.1007/s10067-008-0883-3

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN： 0770-3198            Impact factor:   2.980


× No keyword cloud information.
  2 in total

1.  Treatment-of-choice for Buerger's disease (thromboangiitis obliterans): still an unresolved issue.

Authors:  Kosmas I Paraskevas
Journal:  Clin Rheumatol       Date:  2008-02-02       Impact factor: 2.980

2.  Buerger's disease: a 10-year experience in Tehran, Iran.

Authors:  Hassan Tavakoli; Jalal Rezaii; Khalil Esfandiari; Javad Salimi; Armin Rashidi
Journal:  Clin Rheumatol       Date:  2008-01-03       Impact factor: 2.980
  2 in total
  2 in total

1.  Successful treatment of thromboangiitis obliterans (Buerger's disease) with immunoadsorption: results of a pilot study.

Authors:  Gert Baumann; Verena Stangl; Peter Klein-Weigel; Karl Stangl; Michael Laule; Kathrin Enke-Melzer
Journal:  Clin Res Cardiol       Date:  2011-03-05       Impact factor: 5.460

2.  Management of thromboangiitis obliterans using distraction osteogenesis: A retrospective study.

Authors:  Sunil Kulkarni; Gs Kulkarni; Ashok K Shyam; Milind Kulkarni; Ruta Kulkarni; Vidisha Kulkarni
Journal:  Indian J Orthop       Date:  2011-09       Impact factor: 1.251
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.